📰 For Use News
Page 8 - For Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from For Use. Real-time updates on events, politics, business and more.
June 27, 2021
Bundesregierung macht Veranstaltern Hoffnung auf den Herbst Die Veranstaltungsbranche kann auf einen Neustart im Herbst hoffen. „Mit zunehmender Impfquote bin ich trotz neuer Virusvarianten zuversichtlich, dass wir bald wieder zur Normalität zurückkommen”, sagte Wirtschaftsstaatssekretär Thomas Bareiß (CDU) der „Welt am Sonntag”. Natürlich müssten die Besucher geimpft oder getestet sein. „Wenn jeder ein Impfangebot bekommen hat, gibt es keinen Grund mehr, warum nicht auch Veran...
June 27, 2021
Hunderte Menschen sollen in einer Corona-Krisenregion Norditaliens eine Party gefeiert haben. Alle News zum Coronavirus in unserem Live-Ticker.
June 27, 2021
Immer mehr Menschen in Deutschland sind geimpft. Was bedeutet das für mögliche Großveranstaltungen? Ein Ausblick.
May 17, 2021
As wage workers, the vast majority of us have endless economic problems to worry about — pay and prices, rents and mortgages, sickness, unemployment, old age.
March 10, 2021
Dezeen Daily is sent every day and contains all the latest stories from Dezeen. Dezeen Weekly is a curated newsletter that is sent every Thursday, containing highlights from Dezeen. Dezeen Weekly subscribers will also receive occasional updates about events, competitions and breaking news. We will only use your email address to send you the newsletters you have requested. We will never give your details to anyone else without your consent. You can unsubscribe at any time by clicking on the unsu...
January 19, 2021
The Drug Regulatory Authority of Pakistan (Drap) on Monday approved Chinese state-owned firm Sinopharm COVID-19 vaccine for emergency use, the second vaccine
December 19, 2020
Pfizer/BioNTech vaccine uses messenger RNA (mRNA) technology. Geneva, Switzerland: The Pfizer/BioNTech vaccine has been authorised for use in Switzerland following a two-month rolling review, the Swissmedic regulatory authority said Saturday. "After a meticulous review of the available information, Swissmedic concluded that the Covid-19 vaccine from Pfizer/BioNTech is safe and that its benefit outweighs the risks," the body said in a statement. It is the first vaccine against the new coronavir...